Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharmaand gmbh - oxybutynin hydrochloride 5 mg/5 ml - syrup - 5 mg/5 ml - oxybutynin hydrochloride 1 mg/ml - oxybutynin

Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharmaand gmbh - bendamustine hydrochloride 25 mg - eq. bendamustine 22,7 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 25 mg - bendamustine

Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharmaand gmbh - bendamustine hydrochloride 25 mg - eq. bendamustine 22,7 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 100 mg - bendamustine

Ирландия - английски - HPRA (Health Products Regulatory Authority)

zr pharma& gmbh - clomipramine hydrochloride - prolonged-release tablet - 75 milligram(s) - non-selective monoamine reuptake inhibitors; clomipramine

Малта - английски - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - dutasteride - soft capsule - dutasteride 0.5 mg - urologicals

Малта - английски - Medicines Authority

denk pharma gmbh & co. kg prinzregentenstrasse 79 81675 münchen , germany - apixaban - film-coated tablet - apixaban 5 mg - antithrombotic agents

Великобритания - английски - myHealthbox

midas pharma gmbh - ceftriaxone sodium - powder for solution for injection - 0.596g - antibacterials for systemic use, third generation cephalosporins - it is indicated for the treatment of the following infections in adults and children including term neonates (from birth): • bacterial meningitis • community acquired pneumonia • hospital acquired pneumonia • acute otitis media • intra-abdominal infections • complicated urinary tract infections (including pyelonephritis) • infections of bones and joints • complicated skin and soft tissue infections • gonorrhoea • syphilis • bacterial endocarditis

Великобритания - английски - myHealthbox

midas pharma gmbh - ceftriaxone sodium - powder for solution for infusion - 2.38g - antibacterials for systemic use, third generation cephalosporins - it is indicated for the treatment of the following infections in adults and children including term neonates (from birth): • bacterial meningitis • community acquired pneumonia • hospital acquired pneumonia • acute otitis media • intra-abdominal infections • complicated urinary tract infections (including pyelonephritis) • infections of bones and joints • complicated skin and soft tissue infections • gonorrhoea • syphilis • bacterial endocarditis

Европейски съюз - английски - EMA (European Medicines Agency)

acino pharma gmbh  - clopidogrel - peripheral vascular diseases - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome:- non st segment elevation acute coronary syndrome (unstable angina or non q wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).- st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.for further information please refer to section 5.1.

Европейски съюз - английски - EMA (European Medicines Agency)

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:* patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.